PREVENTION, EARLY DETECTION AND TREATMENT OF GYNAECOLOGICAL CANCER
One of the most important problems for a modern woman is the possibility of malignant disease (cancer) in her genitals (breast, ovary, fallopian tube, uterine, cervical, vaginal, vaginal). The incidence, morbidity and mortality of these diseases is relatively high. Indicatively, cervical cancer continues to kill about 30,000 women in Europe annually and 250,000 women worldwide, and our country annually harms 50-60 women, most of them young, who have not had children, and of them 20 to 25 lose their lives every year.
Gynecological Oncology has now been established as a medical sub-specialty of Obstetrics and Gynecology, which deals with the pathology of the woman’s genital system, prevention, early diagnosis and treatment of gynecological cancer. Gynecological Oncology aims to improve the quality of care provision for cancer patients, who are most likely to be treated, at least in the majority of cases, by specialist gynecologists and oncologists.
The Gynecological Oncology Unit of Mother and Child Medical Center aims at the prevention, early diagnosis and treatment of patients with benign and malignant neoplasms of the female genital tract, as well as patients with recurrence-relapse of previously treated gynecological cancer. Patients are always treated in collaboration with colleagues from other medical specialties (Pathologists, Biopathologists, Molecular Biologists, General Surgeons, Radiologists, Radiotherapists, Pathologists-Oncologists, etc.).
- PREVENTION – EARLY DETECTION OF GYNAECOLOGICAL CANCERS
At Mother and Child Medical Centre we believe screening and testing for the early detection of cancers is key, and we are offering the following:
- Vagina: HPV vaccine, clinical examination, vaginal colposcopy, biopsies, diagnostic procedures
- Uterine cervix: HPV vaccine, clinical examination, Pap smear test, HPV DNA test, colposcopy, biopsies, diagnostic procedures
- Endometrium – Uterine body: clinical examination, transvaginal ultrasound, imaging examinations, diagnostic scraping, diagnostic hysteroscopy, hysteroscopic procedures
- Fallopian Tubes – Ovaries: clinical examination, transvaginal ultrasound, serial molecular blood marker measurements, imaging examinations, diagnostic laparoscopic procedures
- Breast: clinical examination, breast ultrasound, biopsies (FNA),
HPV: In particular, with regard to human papilloma virus (HPV) related diseases of the human genital tract, the following are offered:
- Detection, diagnosis and treatment of HPV-induced lesions:
- precancerous lesions in the uterine cervix (CIN 1/2/3), vagina (VAIN), vulvar (VIN)
- Tumor lesions in the uterine cervix, vagina, vulva, adolescence and perianum (Laser-sublimation)
- Assessment, evaluation and treatment of a Pap smear.
- Evaluation, evaluation and treatment of a positive HPV DNA test.
- Counseling on papillomavirus infection (HPV).
- Advising and conducting the vaccine against HPV.
Apart from the above, our Gynecological Oncology Unit offers general guidance on the prevention of gynecological cancers, particularly for hereditary patients, as well as the full range of routine examinations in the follow-up of patients after the treatment process.
Almost all gynecological cancers are treatable, provided a timely, correct and complete clinical examination by the gynecologist-oncologist, so that either the healing or the best possible prognosis can occur. Examination is the most important part of the patient’s treatment, it is absolutely necessary for diagnosis and helps the doctor to assess the possibilities available for selecting the most appropriate treatment. Early screening makes a decisive contribution to detecting the disease at precancerous or even early stage cancer so that treatment is much easier and with much better prognostic outcomes.
- TREATMENT OF GYNAECOLOGICAL CANCERS
Mother and Child Medical Center treats patients with malignant neoplasms of the female genital tract and breasts. This includes the treatment of both new patients, as well as patients with recurrence-relapse of previously treated gynecological cancers. Patients are always treated in collaboration with colleagues from other medical specialties (Pathologists, Biopathologists, Molecular Biologists, General Surgeons, Radiologists, Radiotherapists, Pathologists-Oncologists, etc.).
Our oncology council is critical in choosing the most appropriate treatment, deliberating with all colleagues involved and all parameters are taken into account based on the patient’s history and health status, with particular emphasis placed on the ability to maintain fertility of the patient where the desire for future childbearing is expressed.
The unique innovation offered by our Gynecological Oncology Unit is the possibility, where appropriate, to use the laparoscopic approach to surgical treatment of benign but mainly malignant cervical, uterine, fallopian and ovaries. This laparoscopic approach is used to either to treat the disease or to stage it, confirming its stage and extent.
The main oncological gynecological interventions are related to:
- Total laparoscopic radical hysterectomy with the method of nerve-sparing with lymphadenectomy.
- Laparoscopic pelvic and paraoralgic lymphadenectomy.
- Laparoscopically assisted radical vaginal trachelectomy with lymphadenctomy.
- Multiple surgical surgery for ovarian, uterine, fallopian and peritoneal cancer.
- Breast Diagnostic and Therapeutic Procedures (Mastectomy, Tumatectomy with Lymphatic Cleansing).
- Breast Reconstruction: As part of the reconstructive breast surgery, the plastic surgeon with the breast surgeon and the patient, together discuss and decide on the most appropriate method of rehabilitation. Its restoration has no effect on disease relapse and does not prevent the postoperative use of prophylactic chemotherapy or radiotherapy.
Our oncology team’s capabilities and experience are key factors in the implementation of the most appropriate surgical techniques in the treatment of various cancers of the female genital tract.